118 related articles for article (PubMed ID: 994969)
1. The effect of an anorectic agent (Mazindol) on control of obese diabetics.
Sanders M; Breidahl H
Med J Aust; 1976 Oct; 2(15):576-7. PubMed ID: 994969
[TBL] [Abstract][Full Text] [Related]
2. Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
Bandisode MS; Boshell BR
Curr Ther Res Clin Exp; 1975 Dec; 18(6):816-24. PubMed ID: 813947
[No Abstract] [Full Text] [Related]
3. AN 448 Sandoz (Mazindol) in the treatment of obesity.
Wallace AG
Med J Aust; 1976 Mar; 1(11):343-5. PubMed ID: 775265
[TBL] [Abstract][Full Text] [Related]
4. Double blind clinical trial of mazindol on weight loss blood glucose, plasma insulin and serum lipids in overweight diabetic patients.
Slama G; Selmi A; Hautecouverture M; Tchobroutsky G
Diabete Metab; 1978 Sep; 4(3):193-9. PubMed ID: 361463
[TBL] [Abstract][Full Text] [Related]
5. Letter: Drugs in obesity.
Jackson WP; Vinik AI
S Afr Med J; 1975 May; 49(20):803. PubMed ID: 1098170
[No Abstract] [Full Text] [Related]
6. [Mazindol in the treatment of obesity in diabetics (author's transl)].
Felt V; Nedvídková J
Cas Lek Cesk; 1977 Sep; 116(39):1214-7. PubMed ID: 922789
[No Abstract] [Full Text] [Related]
7. A double-blind trial of mazindol using a very low calorie formula diet.
Baird IM; Howard AN
Int J Obes; 1977; 1(3):271-8. PubMed ID: 363631
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties and side effects (author's transl)].
Gołebiowska M; Chlebna-Sokół D; Kobierska I; Konopińska A; Małek M; Mastalska A; Zwaigzne-Raczyńska J
Przegl Lek; 1981; 38(3):355-8. PubMed ID: 7017827
[No Abstract] [Full Text] [Related]
9. [Use of teronak for the treatment of obesity with and without diabetes mellitus].
Egart FM; Korotkova VD
Probl Endokrinol (Mosk); 1980; 26(2):16-20. PubMed ID: 7375451
[TBL] [Abstract][Full Text] [Related]
10. [Mazindol in the treatment of obese diabetic patients].
Dolecek R; Reil P; Skarpová O; Závada M
Vnitr Lek; 1976 Aug; 22(8):798-804. PubMed ID: 788327
[No Abstract] [Full Text] [Related]
11. Double-blind cross-over evaluation of mazindol in the treatment of obese hypertensive patients.
Miach PJ; Thomson W; Doyle AE; Louis WJ
Med J Aust; 1976 Sep; 2(10):378-80. PubMed ID: 792640
[TBL] [Abstract][Full Text] [Related]
12. [Mazindol: a new anorectic drug].
Siani V
Clin Ter; 1978 Jan; 84(1):100-1. PubMed ID: 630811
[No Abstract] [Full Text] [Related]
13. [Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity].
Delitala G; Alagna S; Masala A
Clin Ter; 1977 Jun; 81(6):547-54. PubMed ID: 884939
[No Abstract] [Full Text] [Related]
14. Mazindol (Teronac)- another anorectic drug.
Drug Ther Bull; 1974 Dec; 12(26):101-2. PubMed ID: 4459058
[No Abstract] [Full Text] [Related]
15. A multi-centre trial of mazindol ('Teronac') in general practice in Ireland.
Evans ER; Wallace MG
Curr Med Res Opin; 1975; 3(3):132-7. PubMed ID: 1149481
[TBL] [Abstract][Full Text] [Related]
16. Double-blind evaluation of mazindol in refractory obesity.
Smith RG; Innes JA; Munro JF
Br Med J; 1975 Aug; 3(5978):284. PubMed ID: 1097046
[No Abstract] [Full Text] [Related]
17. Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity.
Enzi G; Baritussio A; Marchiori E; Crepaldi G
J Int Med Res; 1976; 4(5):305-18. PubMed ID: 1028632
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the anorectic effect of mazindol and placebo in obesity].
Tatoń J; Czech A; Koliński P; Podwysocka G
Pol Tyg Lek; 1979 Dec; 34(50):1967-70. PubMed ID: 395517
[No Abstract] [Full Text] [Related]
19. A double blind controlled trial of a new anorectic agent AN448.
Woodhouse SP; Nye ER; Anderson K; Rawlings J
N Z Med J; 1975 Jun; 81(542):546-9. PubMed ID: 1099491
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)].
Riesco J; Troncoso G; Costamaillere L; Rodríguez J
Rev Med Chil; 1977 Jun; 105(6):375-9. PubMed ID: 331428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
